In RCC studies, sarcopenia with elevated inflammation, e.g., the modified Glasgow Prognostic Score (mGPS), neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP), was investigated for predicting inferior overall survival (OS) (14, 15). The gene discussed is CRP; the disease is sarcopenia.